June 10, 2025 – Lubrizol announces that an Apisolexâ„¢ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

